True, you can make use of the Gompertz curve to get marginal benefit from waiting a bit while you still have a low marginal probability of non-AGI death.
So we only need to worry about researchers who have lower estimates of unaligned AGI causing their death, or who think that AGI is a long way out and want to hurry it up now.
True, you can make use of the Gompertz curve to get marginal benefit from waiting a bit while you still have a low marginal probability of non-AGI death.
So we only need to worry about researchers who have lower estimates of unaligned AGI causing their death, or who think that AGI is a long way out and want to hurry it up now.